Establishment Labs Holdings (ESTA) Net Income (QoQ) (2017 - 2026)
Establishment Labs Holdings (ESTA) Net Income (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn |
| 3 | Medtronic | 108.10 Bn | 98.88 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.99 Bn | 66.53 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.15 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - |
| 9 | Koninklijke Philips | 23.74 Bn | 20.62 Bn | 2.07 Bn |
| 10 | Establishment Labs Holdings | 2.75 Bn | 2.69 Bn | 42.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -411.74% |
| Dec 31, 2025 | 76.54% |
| Sep 30, 2025 | 32.83% |
| Jun 30, 2025 | 19.88% |
| Mar 31, 2025 | 40.02% |
| Dec 31, 2024 | -107.00% |
| Sep 30, 2024 | 2.90% |
| Jun 30, 2024 | -6.04% |
| Mar 31, 2024 | 21.13% |
| Dec 31, 2023 | 29.83% |
| Sep 30, 2023 | -74.82% |
| Jun 30, 2023 | -40.22% |
| Mar 31, 2023 | 11.95% |
| Dec 31, 2022 | 27.12% |
| Sep 30, 2022 | 49.85% |
| Jun 30, 2022 | -525.42% |
| Mar 31, 2022 | 58.19% |
| Dec 31, 2021 | 3.32% |
| Sep 30, 2021 | -175.80% |
| Jun 30, 2021 | 23.40% |